The absence of any significant differences of γ-H2AX or 53BP1 foci between patients with CIS/early RRMS and healthy controls suggests that lymphocytic DNA double-strand breaks are not associated with CIS/early MS and, therefore, appear unlikely to play a major role in the pathophysiology of MS. The gene discussed is TP53BP1; the disease is myeloid sarcoma.